3rd Quarter - Report

MEHLMAN CONSULTING, INC. for ASTRAZENECA PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform law (PL 111-148) -- implementation issues, including pharmaceutical taxes, Medicaid changes, and comparative effectiveness. (Continued on following page.) H.R. 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010: health care provisions including drug pricing provisions, drug importation, physician payment (SGR), FMAP and COBRA. (Became PL 111-205 on 7/22/10)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th), S. 3551 (111th)

Medicare/Medicaid MMM

Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate issues arising from Deficit Reduction Act. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage. Legislation to address physician payments issues, including SGR and related provisions to Medicare package.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

International trade issues, including free-trade agreements; import safety.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Tax issues, including repatriation, deferral and carried interest. H.R. 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010 (business tax provisions). (Became PL 111-205 on 7/22/10)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th), S. 3551 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.